Dysfunction Patterns of Epoxy-Treated Tissue Heart Valves

Purpose: to perform comparative morphological analysis of causes of dysfunction of epoxy-treated, xenoaortic and xenopericardial, tissues heart valves.

Materials and methods. We included in this study 475 patients with mitral valve disease who have undergone heart valve replacement with tissue valve: (“KemCor”, n=211 [group 1]; “PeriCor”, n=126 [group 2]; and “UniLine”, n=138 [group 3]). Degenerative changes in 26 tissue valves (n=9 “KemCor”, n=11 “PeriCor”, and n=6 “UniLine”) explanted from the mitral position during the repeat replacement were evaluated macroscopically for the presence of calcifications, perforations, leaflet tears and ruptures, pannus, and leaflet fusion to the stent frame. Analysis of survival, freedom from dysfunction and reoperation of the studied tissue heart valves was performed for the period from January 1, 1995 to March 01, 2017.

Results: Pannus overgrowth on the stent struts with extension onto the leaflets was seen on 53.8% of explanted tissue valves. “KemCor” and “PeriCor” tissue valves demonstrated over 70% rate of adhesion formation at the commissure, and in 93% of these cases there were leaflet ruptures at the commissure. Signs of calcification of different grades had 57.6% of specimens. Over 50% of “PeriCor” and “UniLine” tissue valve specimens had calcification at the stent frame. Calcified pannus was noted in 35% of all studied tissue heart valves. Interestingly, dysfunction in 53.3% of the studied tissue heart valves with detected calcification was not associated with calcific deposits. The 6-year actuarial survival for groups I, II and III was 73.5, 66.1 and 87.6%, respectively (group I vs. group II, p=0.6; group II vs. group III - p<0.05; group I vs. group III - p<0.05). The actuarial freedom from reoperation was 81.9%, 75.0% and 94.2%, respectively (p_I-II>0.05; p_II-III<0.05; p_I-III<0.05). The actuarial freedom from dysfunction was 79.6%, 75.0%, and 94.2%, respectively (p_I-II>0.05; p_II-III<0.05; p_I-III<0.05).

Conclusion. The structure of dysfunctions of the studied tissue heart valves was represented by primary tissue failure, calcification and pannus growth. Specific design of the “UniLine” valve allowed to prevent the formation of adhesions between leaflets and the frame in the commissure buttress area, and as a result leaflet rupture from the stent struts. Xenopericardial “UniLine” tissue valves turned out to be superior to xenoaortic “KemCor” and “PeriCor” tissue valves in terms of survival, freedom from reoperations and dysfunction within the 6-year follow-up.

1. Bokeria L.A., Gudkova R.G. Cardiovascular surgery-2015. Disease and congenital anomalies of circulatory system. -M.: A.N. Bakoulev SCCS; 208 p. ISBN 978-5-7982-0367-3

2. Daubert MA, Weissman NJ, Hahn RT, Pibarot P, Parvataneni R, Mack MJ et al. Long-Term Valve Performance of TAVR and SAVR. JACC: Cardiovascular Imaging. 2017;10(1):15-25. DOI: 10.1016/j.jcmg.2016.11.004

3. Barbarash L.S., Stasev A.N., Kokorin S.G., Rutkovskaya N.V., Sizova I.N. Immediate results ofmitral valve-in-valve implantation for bioprosthetic valve dysfunction. Circulation pathology and cardiac surgery. 2015;19(2):36-41.

4. Kudryavtseva Yu.A. Bioprosthetic heart valves. From idea to clinical use. Complex Issues of Cardiovascular Diseases. 2015;4:6-16.

5. Karas'kov A. M., Astapov D. A., Zheleznev S. I., Semenova E. I. KemCor and PeriCor bioprostheses for atrioventricular positions. Network scientific publication “Medicine and education in Siberia." 2012;2.

6. Stasev A.N., Odarenko Yu.N., Rutkovskaya N.V., Zhuravleva I. Yu., Barbarash L.S. Comparison analysis of short-term outcomes following the implantation of xenoaortic and xenopericar-dial epoxy-treated bioprothesis in the mitral position. Complex Issues of Cardiovascular Diseases. 2013;4:12-6.

7. Guo H, Lu C, Huang H, Xie B, Liu J, Zheng S et al. Long-Term Clinical Outcomes of the Carpentier-Edwards Perimount Pericardial Bioprosthesis in Chinese Patients with Single or Multiple Valve Replacement in Aortic, Mitral, or Tricuspid Positions. Cardiology. 2017;138(2):97-106. DOI: 10.1159/000471478

8. Zhuravleva I.Yu., Glushkova T.V., Veremeev A.V., Khryachkova O.N., Loseva S.V., Barbarash L.S. The use of aminodiphosphonate for the prevention of calcification of epoxy-treated bioprostheses. Circulatory pathology and cardiac surgery. 2010;2:18-21.

9. Bottio T, Thiene G, Pettenazzo E, Ius P, Bortolotti U, Rizzoli G et al. Hancock II bioprosthesis: A glance at the microscope in mid-longterm explants. The Journal of Thoracic and Cardiovascular Surgery. 2003;126(1):99-105. DOI: 10.1016/S0022-5223(03)00131-4

10. Chan V Malas T, Lapierre H, Boodhwani M, Lam B-K, Rubens FD et al. Reoperation of Left Heart Valve Bioprostheses According to Age at Implantation. Circulation. 2011;124(11 Suppl 1):S75-80. DOI: 10.1161/CIRCULATIONAHA.110.011973

11. Karas'kov A.M., Zheleznev S.I., Nazarov V.M., Lavinyukov S.O., Larionov P.M., Bogachev-ProkofievAV. et al. Clinical and morphological alterations in the dysfunction of biological heart prostheses. Circulatory pathology and cardiac surgery. 2006;2:21-6.

12. Oda T, Kato S, Tayama E, Fukunaga S, Akashi H, Aoyagi S. Pannus overgrowth after mitral valve replacement with a Carpentier-Edwards pericardial bioprosthesis. Journal of Artificial Organs. 2009;12(1):55-7. DOI: 10.1007/s10047-008-0445-0

13. Butany JW, Kesarwani R, Yau TM, Singh G, Thangaroopan M, Nair V et al. The Role of Pannus in the Longevity of an Ionescu-Shiley Pericardial Bioprosthesis. Journal of Cardiac Surgery. 2006;21(5):505-7. DOI: 10.1111/j.1540-8191.2006.00286.x

14. Gellis L, Baird CW, Emani S, Borisuk M, Gauvreau K, Padera RF et al. Morphologic and histologic findings in bioprosthetic valves explanted from the mitral position in children younger than 5 years of age. The Journal of Thoracic and Cardiovascular Surgery. 2018;155(2):746-52. DOI: 10.1016/j.jtcvs.2017.09.091

15. Mazzarella G, Bianco A, Lucariello A, Savarese L, Fiumarella A, Cerasuolo F et al. Cardiovascular prosthetic surgery: an analysis of cellular and molecular patterns underlying valve implantation failure. In Vivo (Athens, Greece). 2012;26(2):271-5. PMID: 22351669

16. Anderson JM. Biological Responses to Materials. Annual Review of Materials Research. 2001;31(1):81-110. DOI: 10.1146/annurev.matsci.31.1.81

17. Halevi R, Hamdan A, Marom G, Mega M, Raanani E, Haj-Ali R. Progressive aortic valve calcification: Three-dimensional visualization and biomechanical analysis. Journal of Biomechanics. 2015;48(3):489-97. DOI: 10.1016/j.jbiomech.2014.12.004

18. Pukhov D.E., Vasilev S.V., Zotov A.S., Ilin M.V., Rudy A.S. Micromorphology, composition and localization habits of mineral deposits of aortal valve cusps according to the scanning electron microscopy and X-ray diffractometry. Bulletin of Pirogov National Medical and Surgical Center. 2014;9(1):23-30.